Cardiovascular Systems announces acquisition of peripheral support catheters From WavePoint Medical

2040

Cardiovascular Systems recently announced that it has acquired a line of peripheral support catheters from WavePoint Medical.

Peripheral support catheters are used during peripheral vascular intervention (PVI) procedures for guidewire support to enable lesion crossing, as well as for guidewire exchanges. Physicians use support catheters in approximately 50% of PVIs, primarily in below-the-knee and complex interventions. When calcium is present, lesions can be challenging to cross with an interventional guidewire and often require advanced tools prior to vessel preparation and treatment. CSI anticipates it will introduce the acquired catheters as its new ViperCross line in the first half of its fiscal year ending 30 June 2022.

In addition, as part of this transaction, WavePoint will also develop a portfolio of specialty catheters used in the treatment of chronic total occlusions (CTO) and complex percutaneous coronary intervention (PCI) procedures for CSI. CTOs represent a significant and growing segment of PCIs and often contribute to poor patient outcomes. Commercial availability of these specialty catheters is anticipated in CSI’s fiscal year ending 30 June 2023.


LEAVE A REPLY

Please enter your comment!
Please enter your name here